These results demonstrated that the centrosome-related prognostic model based on these three candidate genes (MAPK10, EIF4EBP1, PSME2) shows high accuracy and considerable stability in predicting the prognoses of breast cancers. This evidence concerns the gene MAPK10 and breast cancer.